Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections.

Nile C, Falleni M, Cirasola D, Alghamdi A, Anderson OF, Delaney C, Ramage G, Ottaviano E, Tosi D, Bulfamante G, Morace G, Borghi E.

mSphere. 2019 Jan 23;4(1). pii: e00689-18. doi: 10.1128/mSphere.00689-18.

2.

Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.

Lovero G, Borghi E, Balbino S, Cirasola D, De Giglio O, Perdoni F, Caggiano G, Morace G, Montagna MT.

PLoS One. 2016 Feb 26;11(2):e0150218. doi: 10.1371/journal.pone.0150218. eCollection 2016.

3.

Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm.

Perdoni F, Signorelli P, Cirasola D, Caretti A, Galimberti V, Biggiogera M, Gasco P, Musicanti C, Morace G, Borghi E.

BMC Microbiol. 2015 Oct 30;15:248. doi: 10.1186/s12866-015-0588-0.

4.

Methicillin-Resistant Staphylococcus aureus in Raw Milk: Prevalence, SCCmec Typing, Enterotoxin Characterization, and Antimicrobial Resistance Patterns.

Riva A, Borghi E, Cirasola D, Colmegna S, Borgo F, Amato E, Pontello MM, Morace G.

J Food Prot. 2015 Jun;78(6):1142-6. doi: 10.4315/0362-028X.JFP-14-531.

5.

A histological procedure to study fungal infection in the wax moth Galleria mellonella.

Perdoni F, Falleni M, Tosi D, Cirasola D, Romagnoli S, Braidotti P, Clementi E, Bulfamante G, Borghi E.

Eur J Histochem. 2014 Sep 23;58(3):2428. doi: 10.4081/ejh.2014.2428.

6.

Correlation between Candida albicans biofilm formation and invasion of the invertebrate host Galleria mellonella.

Borghi E, Romagnoli S, Fuchs BB, Cirasola D, Perdoni F, Tosi D, Braidotti P, Bulfamante G, Morace G, Mylonakis E.

Future Microbiol. 2014;9(2):163-73. doi: 10.2217/fmb.13.159.

PMID:
24571071
7.

Antifungal resistance does not necessarily affect Candida glabrata fitness.

Borghi E, Andreoni S, Cirasola D, Ricucci V, Sciota R, Morace G.

J Chemother. 2014 Feb;26(1):32-6. doi: 10.1179/1973947813Y.0000000100. Epub 2013 Dec 6.

PMID:
24091025
8.

Experimental biofilm-related Candida infections.

Cirasola D, Sciota R, Vizzini L, Ricucci V, Morace G, Borghi E.

Future Microbiol. 2013 Jun;8(6):799-805. doi: 10.2217/fmb.13.36.

PMID:
23701334
9.

Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus.

Furi L, Ciusa ML, Knight D, Di Lorenzo V, Tocci N, Cirasola D, Aragones L, Coelho JR, Freitas AT, Marchi E, Moce L, Visa P, Northwood JB, Viti C, Borghi E, Orefici G; BIOHYPO Consortium, Morrissey I, Oggioni MR.

Antimicrob Agents Chemother. 2013 Aug;57(8):3488-97. doi: 10.1128/AAC.00498-13. Epub 2013 May 13.

10.

Lack of evidence for reduced fitness of clinical Staphylococcus aureus isolates with reduced susceptibility to triclosan.

Oggioni MR, Ciusa ML, Furi L, Baldassarri L, Orefici G, Cirasola D, Martinez JL, Morrissey I, Borghi E.

Antimicrob Agents Chemother. 2012 Nov;56(11):6068-9; author reply 6072. doi: 10.1128/AAC.01055-12. No abstract available.

11.

Cell surface hydrophobicity: a predictor of biofilm production in Candida isolates?

Borghi E, Sciota R, Biassoni C, Cirasola D, Cappelletti L, Vizzini L, Boracchi P, Morace G.

J Med Microbiol. 2011 May;60(Pt 5):689-90. doi: 10.1099/jmm.0.026898-0. Epub 2011 Jan 27. No abstract available.

PMID:
21273372

Supplemental Content

Loading ...
Support Center